Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease

Journal of Parkinson’s Disease · Published 2026-09-18 · Journal article · DOI 10.1177/1877718x261479077

Free full text

Authors (13)

Maria Ilenia De Bartolo, Francesco Marchet, Sara Pietracupa, Carolina Cutrona, Flavia Aiello, Matteo Costanzo, Giorgio Leodori, Giorgio Vivacqua, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Nicola Modugno, Daniele Belvisi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bartolo, M., Marchet, F., Pietracupa, S., et al. (2026). Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x261479077

Related articles

• Apomorphine for Parkinson’s disease: pharmacologic and clinical considerations · EXPERT OPINION ON EMERGING DRUGS · 2023 · Cites or is cited by this article
• Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms · Journal of Parkinson’s Disease · 2025 · Same journal
• A review of FDG-PET biomarker analysis methods in Parkinson's disease · Journal of Parkinson’s Disease · 2026 · Same journal
• Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis · Journal of Parkinson’s Disease · 2026 · Same journal
• Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort · Journal of Parkinson’s Disease · 2026 · Same journal
• Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape · Journal of Parkinson’s Disease · 2026 · Same journal
• Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development · Journal of Parkinson’s Disease · 2026 · Same journal
• Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts · Journal of Parkinson’s Disease · 2026 · Same journal
• Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives · Journal of Parkinson’s Disease · 2025 · Same journal